Credit Agricole’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.3M | Sell |
38,977
-53,439
| -58% | -$36.4M | 0.05% | 282 |
|
|
2026
Q1 | $71.4M | Sell |
92,416
-16,527
| -15% | -$12.7M | 0.19% | 98 |
|
|
2025
Q4 | $84.1M | Buy |
108,943
+74,499
| +216% | +$50.6M | 0.19% | 89 |
|
|
2025
Q3 | $19.4M | Buy |
+34,444
| New | +$19.5M | 0.05% | 265 |
|
|
2025
Q1 | $3.74M | Sell |
5,898
-5,224
| -47% | -$3.59M | 0.01% | 598 |
|
|
2024
Q4 | $7.92M | Sell |
11,122
-10,650
| -49% | -$8.94M | 0.02% | 450 |
|
|
2024
Q3 | $22.9M | Buy |
21,772
+12,354
| +131% | +$13.7M | 0.1% | 155 |
|
|
2024
Q2 | $9.9M | Buy |
9,418
+745
| +9% | +$722K | 0.05% | 241 |
|
|
2024
Q1 | $7.75M | Buy |
8,673
+3,489
| +67% | +$3.32M | 0.08% | 197 |
|
|
2023
Q4 | $4.55M | Buy |
5,184
+1,289
| +33% | +$1.06M | 0.05% | 225 |
|
|
2023
Q3 | $3.21M | Buy |
3,895
+259
| +7% | +$204K | 0.05% | 238 |
|
|
2023
Q2 | $2.61M | Buy |
3,636
+160
| +5% | +$123K | 0.05% | 224 |
|
|
2023
Q1 | $2.86M | Buy |
3,476
+204
| +6% | +$154K | 0.06% | 196 |
|
|
2022
Q4 | $2.36M | Sell |
3,272
-2,113
| -39% | -$1.56M | 0.05% | 225 |
|
|
2022
Q3 | $3.71M | Buy |
5,385
+2,714
| +102% | +$1.71M | 0.07% | 175 |
|
|
2022
Q2 | $1.58M | Buy |
2,671
+2,418
| +956% | +$1.57M | 0.04% | 268 |
|
|
2022
Q1 | $177K | Sell |
253
-250
| -50% | -$158K | ﹤0.01% | 431 |
|
|
2021
Q4 | $318K | Hold |
503
| – | – | 0.01% | 376 |
|
|
2021
Q3 | $304K | Sell |
503
-100
| -17% | -$62.1K | 0.01% | 354 |
|
|
2021
Q2 | $337K | Sell |
603
-83
| -12% | -$42K | 0.01% | 317 |
|
|
2021
Q1 | $324K | Buy |
686
+300
| +78% | +$146K | 0.01% | 295 |
|
|
2020
Q4 | $187K | Sell |
386
-12,633
| -97% | -$6.82M | 0.01% | 324 |
|
|
2020
Q3 | $7.29M | Buy |
13,019
+602
| +5% | +$365K | 0.39% | 70 |
|
|
2020
Q2 | $7.74M | Buy |
12,417
+3,250
| +35% | +$1.84M | 0.49% | 54 |
|
|
2020
Q1 | $4.48M | Buy |
9,167
+9,019
| +6,094% | +$3.72M | 0.38% | 65 |
|
|
2019
Q4 | $56K | Hold |
148
| – | – | ﹤0.01% | 309 |
|
|
2019
Q3 | $41K | Hold |
148
| – | – | ﹤0.01% | 386 |
|
|
2019
Q2 | $46K | Buy |
148
+48
| +48% | +$16K | ﹤0.01% | 379 |
|
|
2019
Q1 | $41K | Hold |
100
| – | – | ﹤0.01% | 389 |
|
|
2018
Q4 | $37K | Hold |
100
| – | – | ﹤0.01% | 406 |
|
|
2018
Q3 | $40K | Hold |
100
| – | – | ﹤0.01% | 383 |
|
|
2018
Q2 | $34K | Buy |
+100
| New | +$31.3K | ﹤0.01% | 345 |
|
|
2017
Q4 | – | Sell |
-47,332
| Closed | -$21.2M | – | 913 |
|
|
2017
Q3 | $21.2M | Buy |
47,332
+21,614
| +84% | +$10.3M | 0.07% | 283 |
|
|
2017
Q2 | $12.6M | Buy |
25,718
+2,142
| +9% | +$937K | 0.04% | 427 |
|
|
2017
Q1 | $9.14M | Buy |
23,576
+8,375
| +55% | +$3.1M | 0.03% | 578 |
|
|
2016
Q4 | $5.58M | Buy |
15,201
+661
| +5% | +$251K | 0.02% | 667 |
|
|
2016
Q3 | $5.85M | Buy |
14,540
+1,109
| +8% | +$445K | 0.02% | 639 |
|
|
2016
Q2 | $4.69M | Buy |
13,431
+477
| +4% | +$184K | 0.02% | 636 |
|
|
2016
Q1 | $4.67M | Sell |
12,954
-1,677
| -11% | -$691K | 0.02% | 577 |
|
|
2015
Q4 | $7.94M | Sell |
14,631
-10,911
| -43% | -$5.91M | 0.04% | 430 |
|
|
2015
Q3 | $11.9M | Buy |
25,542
+7,653
| +43% | +$4.11M | 0.06% | 347 |
|
|
2015
Q2 | $9.13M | Sell |
17,889
-1,574
| -8% | -$768K | 0.04% | 433 |
|
|
2015
Q1 | $8.79M | Sell |
19,463
-4,935
| -20% | -$2.09M | 0.04% | 459 |
|
|
2014
Q4 | $9.95M | Sell |
24,398
-93,253
| -79% | -$36.7M | 0.04% | 439 |
|
|
2014
Q3 | $42.4M | Sell |
117,651
-8,342
| -7% | -$2.8M | 0.18% | 130 |
|
|
2014
Q2 | $35.6M | Sell |
125,993
-21,154
| -14% | -$6.27M | 0.15% | 166 |
|
|
2014
Q1 | $44.2M | Buy |
147,147
+32,412
| +28% | +$9.99M | 0.18% | 155 |
|
|
2013
Q4 | $31.6M | Buy |
114,735
+99,067
| +632% | +$28.5M | 0.13% | 206 |
|
|
2013
Q3 | $4.9M | Buy |
+15,668
| New | +$4.12M | 0.02% | 605 |
|
Other funds holding REGN
Credit Agricole's REGN Position: Q2 2026 in Review
Credit Agricole reduced its Regeneron Pharmaceuticals (REGN) stake by 58% in Q2 2026, selling an estimated $36.4M and leaving 38,977 shares worth $24.3M. The position accounts for 0.05% of the portfolio, ranked #282.
Credit Agricole first reported a position in REGN in Q3 2013 and has held it in 49 quarters since. The position peaked at $84.1M in Q4 2025. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Credit Agricole held 38,977 shares of Regeneron Pharmaceuticals worth $24.3M as of Q2 2026.
- Credit Agricole sold 53,439 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $36.4M.
- Regeneron Pharmaceuticals made up 0.05% of Credit Agricole's portfolio in Q2 2026, its #282 holding.
- Credit Agricole first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 49 quarters since.
- Credit Agricole's Regeneron Pharmaceuticals position peaked at $84.1M in Q4 2025.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.